Status:
UNKNOWN
TransCranial Doppler for REDUCtion of Silent strokE During MitraClip Implantation
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Berlin Institute of Health
Conditions:
Mitral Valve Insufficiency
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary goal of the TCD-REDUCE study is to demonstrate the effectiveness of continuous transcranial Doppler sonography ("sonolysis") on the reduction of the ischemic stroke volume during MitraClip...
Detailed Description
Cardiac procedures are associated with new cerebral ischemic lesions detected on diffusion-weighted MRI (Bendszus et al., 2006). A previous study suggests that sonolysis (continuous transcranial Dopp...
Eligibility Criteria
Inclusion
- Patients with mitral regurgitation that are assigned to the MitraClip implantation by an interdisciplinary heart team according to current guidelines.
Exclusion
- contraindication to MRI examination (e.g. pace-maker, implanted metal material, claustrophobia)
- pregnancy
- unable to consent
- no transtemporal window
Key Trial Info
Start Date :
August 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04384198
Start Date
August 13 2020
End Date
December 1 2024
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité-Campus Benjamin Franklin
Berlin, Germany, 12200